Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 14;14(20):5023.
doi: 10.3390/cancers14205023.

Machine Learning for Risk Prediction of Oesophago-Gastric Cancer in Primary Care: Comparison with Existing Risk-Assessment Tools

Affiliations

Machine Learning for Risk Prediction of Oesophago-Gastric Cancer in Primary Care: Comparison with Existing Risk-Assessment Tools

Emma Briggs et al. Cancers (Basel). .

Abstract

Oesophago-gastric cancer is difficult to diagnose in the early stages given its typical non-specific initial manifestation. We hypothesise that machine learning can improve upon the diagnostic performance of current primary care risk-assessment tools by using advanced analytical techniques to exploit the wealth of evidence available in the electronic health record. We used a primary care electronic health record dataset derived from the UK General Practice Research Database (7471 cases; 32,877 controls) and developed five probabilistic machine learning classifiers: Support Vector Machine, Random Forest, Logistic Regression, Naïve Bayes, and Extreme Gradient Boosted Decision Trees. Features included basic demographics, symptoms, and lab test results. The Logistic Regression, Support Vector Machine, and Extreme Gradient Boosted Decision Tree models achieved the highest performance in terms of accuracy and AUROC (0.89 accuracy, 0.87 AUROC), outperforming a current UK oesophago-gastric cancer risk-assessment tool (ogRAT). Machine learning also identified more cancer patients than the ogRAT: 11.0% more with little to no effect on false positives, or up to 25.0% more with a slight increase in false positives (for Logistic Regression, results threshold-dependent). Feature contribution estimates and individual prediction explanations indicated clinical relevance. We conclude that machine learning could improve primary care cancer risk-assessment tools, potentially helping clinicians to identify additional cancer cases earlier. This could, in turn, improve survival outcomes.

Keywords: cancer diagnosis; early detection; electronic health record; machine learning; oesophago-gastric cancer; primary care; risk-assessment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. The views expressed in this article are those of the author(s) and not necessarily those of the NHS, the NIHR, UKRI EPSRC, TPP, Cancer Research UK, Macmillan Cancer Support, or the Department of Health and Social Care.

Figures

Figure 1
Figure 1
Feature importance graph displaying relative contribution of diagnostic factors for oesophago-gastric cancer to model risk score. Model: Support Vector Machine (with linear kernel). Feature weights represented by model coefficients. Generated with matplotlib [41].

Similar articles

Cited by

References

    1. Allum W., Lordick F., Alsina M., Andritsch E., Ba-Ssalamah A., Beishon M., Braga M., Caballero C., Carneiro F., Cassinello F., et al. ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer. Crit. Rev. Oncol. Hematol. 2018;122:179–193. doi: 10.1016/j.critrevonc.2017.12.019. - DOI - PubMed
    1. Cancer Research UK UK Oesophageal Cancer Statistics. London, UK. 2019. [(accessed on 1 December 2021)]. Available online: https://www.cancerresearchuk.org/health-professional/cancer-statistics/s....
    1. Cancer Research UK UK Stomach Cancer Statistics. London, UK. 2019. [(accessed on 1 December 2021)]. Available online: https://www.cancerresearchuk.org/health-professional/cancer-statistics/s....
    1. Swann R., McPhail S., Witt J., Shand B., Abel G.A., Hiom S., Rashbass J., Lyratzopoulos G., Rubin G., The National Cancer Diagnosis Audit Steering Group Diagnosing cancer in primary care: Results from the National Cancer Diagnosis Audit. Br. J. Gen. Pract. 2018;68:e63–e72. doi: 10.3399/bjgp17X694169. - DOI - PMC - PubMed
    1. Arnold M., Rutherford M.J., Bardot A., Ferlay J., Andersson T.M.L., Myklebust T.Å., Tervonen H., Thursfield V., Ransom D., Shack L., et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): A population-based study. Lancet Oncol. 2019;20:1493–1505. doi: 10.1016/S1470-2045(19)30456-5. - DOI - PMC - PubMed